A rapid and reliable test for BRCA1 and BRCA2 founder mutation analysis in paraffin tissue using pyrosequencing Journal Article


Authors: Zhang, L.; Kirchhoff, T.; Yee, C. J.; Offit, K.
Article Title: A rapid and reliable test for BRCA1 and BRCA2 founder mutation analysis in paraffin tissue using pyrosequencing
Abstract: The founder mutations in BRCA (BRCA1*185delAG, BRCA1*5382insC, and BRCA2*6174delT) account for 95% of the detectable BRCA mutations in breast and ovarian cancer families of Ashkenazi Jewish ancestry. Optimal clinical management of individuals from these high-risk families relies on the identification of BRCA founder mutations in the laboratory. We have therefore developed a rapid and reliable approach using pyrosequencing, which allows for the detection of these frequent frameshift mutations on different types of specimens. We were able to correctly identify all mutants in a blinded analysis of 177 DNA samples, including 120 DNA samples extracted from paraffin tissues, 30 samples derived from blood specimens, and 27 samples derived from saliva. The mutation detection rate of pyrosequencing was 100% for all of the DNA samples tested with neither false-positive nor false-negative results. The assay also demonstrated both high accuracy and high precision for the detection of these common mutations in paraffin tissues. Furthermore, saliva collection is a noninvasive alternative for DNA isolation in both clinical and research settings. We show that pyrosequencing is a rapid and reliable method that serves as an excellent platform for BRCA founder mutation analysis, especially when only paraffin-embedded tissues are available. Copyright © American Society for Investigative Pathology and the Association for Molecular Pathology.
Keywords: controlled study; gene mutation; frameshift mutation; genetics; molecular genetics; methodology; laboratory diagnosis; genetic analysis; reproducibility; accuracy; reproducibility of results; mutational analysis; brca1 protein; brca2 protein; time; time factors; false negative result; economics; molecular sequence data; blood analysis; nucleotide sequence; clinical research; base sequence; dna mutational analysis; founder effect; non invasive measurement; paraffin; pyrosequencing; dna isolation; saliva analysis; paraffin embedding
Journal Title: Journal of Molecular Diagnostics
Volume: 11
Issue: 3
ISSN: 1525-1578
Publisher: Elsevier Science, Inc.  
Date Published: 2009-05-01
Start Page: 176
End Page: 181
Language: English
DOI: 10.2353/jmoldx.2009.080137
PUBMED: 19324993
PROVIDER: scopus
PMCID: PMC2671333
DOI/URL:
Notes: --- - "Cited By (since 1996): 2" - "Export Date: 30 November 2010" - "CODEN: JMDIF" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Kenneth Offit
    790 Offit
  2. Cindy J Yee
    12 Yee
  3. Liying Zhang
    129 Zhang